Insider Transactions in Q3 2025 at Madrigal Pharmaceuticals, Inc. (MDGL)
Insider Transaction List (Q3 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 09
2025
|
William John Sibold President and CEO |
SELL
Open market or private sale
|
Direct |
7,279
-6.63%
|
$3,239,155
$445.63 P/Share
|
Aug 21
2025
|
William John Sibold President and CEO |
SELL
Open market or private sale
|
Direct |
7,616
-3.27%
|
$3,046,400
$400.51 P/Share
|
Aug 20
2025
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
59,901
+0.24%
|
$23,001,984
$384.95 P/Share
|
Aug 18
2025
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
105,782
+0.31%
|
$38,504,648
$364.61 P/Share
|
Aug 18
2025
|
Shannon T Kelley General Counsel |
SELL
Open market or private sale
|
Direct |
1,304
-1.64%
|
$483,784
$371.08 P/Share
|
Aug 15
2025
|
Kenneth Bate Director |
SELL
Open market or private sale
|
Direct |
10,000
-22.74%
|
$3,650,000
$365.89 P/Share
|
Aug 15
2025
|
Kenneth Bate Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.2%
|
$160,000
$16.46 P/Share
|
Aug 13
2025
|
Paul A Friedman Director |
SELL
Open market or private sale
|
Direct |
129,172
-2.97%
|
$47,276,952
$366.29 P/Share
|
Aug 13
2025
|
Paul A Friedman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
129,172
+28.99%
|
$1,162,548
$9.45 P/Share
|
Aug 12
2025
|
Paul A Friedman Director |
SELL
Open market or private sale
|
Direct |
43,605
-2.07%
|
$15,479,775
$355.37 P/Share
|
Aug 12
2025
|
Paul A Friedman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
43,605
+15.89%
|
$392,445
$9.45 P/Share
|
Aug 12
2025
|
Rebecca Taub Director |
SELL
Open market or private sale
|
Direct |
43,263
-0.89%
|
$15,358,365
$355.31 P/Share
|
Aug 12
2025
|
Rebecca Taub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
43,263
+7.9%
|
$389,367
$9.45 P/Share
|
Aug 11
2025
|
Paul A Friedman Director |
SELL
Open market or private sale
|
Direct |
3,203
-0.84%
|
$1,121,050
$350.62 P/Share
|
Aug 11
2025
|
Paul A Friedman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,203
+1.65%
|
$28,827
$9.45 P/Share
|
Aug 11
2025
|
Rebecca Taub Director |
SELL
Open market or private sale
|
Direct |
3,200
-0.34%
|
$1,120,000
$350.6 P/Share
|
Aug 11
2025
|
Rebecca Taub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,200
+0.68%
|
$28,800
$9.45 P/Share
|
Aug 01
2025
|
Daniel J. Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
967
+50.0%
|
-
|
Jul 18
2025
|
Paul A Friedman Director |
SELL
Open market or private sale
|
Direct |
1,400
-0.74%
|
$490,000
$350.03 P/Share
|
Jul 18
2025
|
Paul A Friedman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+0.74%
|
$12,600
$9.45 P/Share
|
Jul 18
2025
|
Rebecca Taub Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.22%
|
$350,000
$350.0 P/Share
|
Jul 18
2025
|
Rebecca Taub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.22%
|
$9,000
$9.45 P/Share
|
Jul 17
2025
|
Rebecca Taub Director |
SELL
Open market or private sale
|
Direct |
2,657
-0.29%
|
$929,950
$350.79 P/Share
|
Jul 17
2025
|
Rebecca Taub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,657
+0.57%
|
$23,913
$9.45 P/Share
|
Jul 17
2025
|
Paul A Friedman Director |
SELL
Open market or private sale
|
Direct |
2,700
-0.71%
|
$945,000
$350.84 P/Share
|
Jul 17
2025
|
Paul A Friedman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,700
+1.4%
|
$24,300
$9.45 P/Share
|
Jul 16
2025
|
Rebecca Taub Director |
SELL
Open market or private sale
|
Direct |
26,444
-0.79%
|
$9,334,732
$353.54 P/Share
|
Jul 16
2025
|
Rebecca Taub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,444
+5.15%
|
$237,996
$9.45 P/Share
|
Jul 16
2025
|
Paul A Friedman Director |
SELL
Open market or private sale
|
Direct |
26,176
-1.85%
|
$9,240,128
$353.56 P/Share
|
Jul 16
2025
|
Paul A Friedman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,176
+10.93%
|
$235,584
$9.45 P/Share
|